Literature DB >> 9543211

Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder. Psychometric performance of four self-report measures.

N K Leidy1, C Palmer, M Murray, J Robb, D A Revicki.   

Abstract

The purpose of this study was to evaluate the psychometric properties of selected health-related quality of life (HRQL) self-report measures in 62 euthymic and depressed patients diagnosed with bipolar disorder. Patients completed the Quality of Life in Depression Scale (QLDS), Mental Health Index-17 (MHI-17), Cognitive Function Scale, and Medical Outcomes Study Short Form-36 (SF-36) at baseline and 8 weeks following treatment. Hamilton and Young Rating Scales were used to assess clinical status and validate the HRQL measures. The MHI-17, Cognitive Function Scale, QLDS, and SF-36 social function, vitality, role limitations-emotional, and mental health scales have good reliability and validity, and are responsive to changes in clinical status in patients with bipolar disorder. Although the small sample size limits generalizablity, euthymic and depressed outpatients with bipolar disorder appear to contribute reliable self reports on selected aspects of their quality of life.

Entities:  

Mesh:

Year:  1998        PMID: 9543211     DOI: 10.1016/s0165-0327(97)00147-x

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  23 in total

Review 1.  A review of the health-related quality of life literature in bipolar disorder.

Authors:  M A Namjoshi; D P Buesching
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Measuring health-related quality of life in bipolar disorder: relationship of the EuroQol (EQ-5D) to condition-specific measures.

Authors:  Hazel Hayhurst; Stephen Palmer; Rosemary Abbott; Tony Johnson; Jan Scott
Journal:  Qual Life Res       Date:  2006-09-14       Impact factor: 4.147

Review 3.  Quality of life and subthreshold affective symptoms.

Authors:  Arianna Goracci; Mirko Martinucci; Umberto Scalcione; Andrea Fagiolini; Paolo Castrogiovanni
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

Review 4.  Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials.

Authors:  Dennis A Revicki; Louis S Matza; Emuella Flood; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 5.  Economics of atypical antipsychotics in bipolar disorder: a review of the literature.

Authors:  Rachael L Fleurence; Julia M Dixon; Dennis A Revicki
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis.

Authors:  Tyler B Grove; Ivy F Tso; Jinsoo Chun; Savanna A Mueller; Stephan F Taylor; Vicki L Ellingrod; Melvin G McInnis; Patricia J Deldin
Journal:  Psychiatry Res       Date:  2016-06-25       Impact factor: 3.222

7.  Faith and mental health in an oncology population.

Authors:  Janice Bell Meisenhelder; Nancy J Schaeffer; Jerry Younger; Marisa Lauria
Journal:  J Relig Health       Date:  2013-06

8.  Geriatric Assessment in Older Adults with Multiple Myeloma.

Authors:  Tanya M Wildes; Sascha A Tuchman; Heidi D Klepin; Joseph Mikhael; Kathryn Trinkaus; Keith Stockerl-Goldstein; Ravi Vij; Graham Colditz
Journal:  J Am Geriatr Soc       Date:  2018-12-13       Impact factor: 5.562

9.  Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain.

Authors:  Monica Tafalla; Luis Salvador-Carulla; Jerónimo Saiz-Ruiz; Teresa Diez; Luis Cordero
Journal:  BMC Psychiatry       Date:  2010-04-28       Impact factor: 3.630

10.  A comparison of quality of life and depression between female married immigrants and native married women in Taiwan.

Authors:  Frank Huang-Chih Chou; Pei-Chun Chen; Renyi Liu; Chi-Kung Ho; Kuan-Yi Tsai; Wen-Wei Ho; Shin-Shin Chao; Kung-Shih Lin; Shih-Pei Shen; Cheng-Chung Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-09       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.